Palivizumab injection is used to prevent serious lung infection in children and babies caused by respiratory syncytial virus ...

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...

which used McLellan and Graham’s research to stabilize the RSV fusion protein and enable the body to develop strong antibodies against it, according to UT. “Getting into structure-based vacc ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

The acquisition focuses on sisunotavir, an RSV fusion inhibitor that UK-based ReViral ... including a follow-up RSV candidate targeting the viral N protein that is in phase 1 testing.

Canada anticipates at least two new products; nirsevimab, a long-acting monoclonal antibody, and an RSV stabilized pre-fusion subunit protein vaccine for pregnant women and people (Pfizer RSVpreF ...

The fusion between Swedish pharmaceutical ... including several different approaches towards Hepatitis C and Respiratory Syncytial Virus (RSV). It was around this point that AZ decided to re ...

HMPV is a non-segmented negative sense, single-strand RNA virus, size: 13,300 ~ nucleotides, 8 genes coding for 9 open reading frames (ORFs) that includes a sequence for fusion (F) and attachment ...